Literature DB >> 4142957

Reserpine use in relation to breast cancer.

O P Heinonen, S Shapiro, L Tuominen, M I Turunen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4142957     DOI： 10.1016/s0140-6736(74)93259-0

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  27 in total

Review 1.  [Reserpine-diuretic combinations in therapy of arterial hypertension. Current considerations].

Authors:  M Siepmann; W Kirch
Journal:  Med Klin (Munich)       Date:  1998-12-15

Review 2.  Angiotensin receptor blockers and tumorigenesis: something to be (or not to be) concerned about?

Authors:  Vadim Tchaikovski; Gregory Y H Lip
Journal:  Curr Hypertens Rep       Date:  2012-06       Impact factor: 5.369

Review 3.  Reserpine: a relic from the past or a neglected drug of the present for achieving cost containment in treating hypertension?

Authors:  G J Magarian
Journal:  J Gen Intern Med       Date:  1991 Nov-Dec       Impact factor: 5.128

4.  Analysis of individual drug use as a time-varying determinant of exposure in prospective population-based cohort studies.

Authors:  B H Ch Stricker; T Stijnen
Journal:  Eur J Epidemiol       Date:  2010-04-01       Impact factor: 8.082

Review 5.  Antihypertensive drugs: clinical pharmacology and therapeutic use.

Authors:  G L Wollam; R W Gifford; R C Tarazi
Journal:  Drugs       Date:  1977-12       Impact factor: 9.546

6.  A multicentre study of rauwolfia derivates and breast cancer.

Authors:  L J Christopher; J Crooks; J F Davidson; Z G Erskine; S C Gallon; D C Moir; R D Weir
Journal:  Eur J Clin Pharmacol       Date:  1977-07-19       Impact factor: 2.953

7.  Review of marketed medicinal products: review procedures in Finland and Norway.

Authors:  J Idänpään-Heikkilä
Journal:  Agents Actions       Date:  1978-06

8.  The incidence of cancer in schizophrenic patients.

Authors:  P B Mortensen
Journal:  J Epidemiol Community Health       Date:  1989-03       Impact factor: 3.710

9.  Prolactin secretion during reserpine and syrosingopine treatment.

Authors:  E Camanni; E Strumia; P Portaleone; G M Molinatti
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

10.  Mild hypertension: a clinical trial conducted in hospital general practice.

Authors:  H E Joesbury; C A Phillips; R T Garrett; E Wilkes; A J Smith
Journal:  Br Med J       Date:  1976-12-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.